Ceramide-induced apoptosis in Fas-resistant Hodgkin's disease cell lines is caspase independent

Experimental Cell Research

Volumn 255, Issue 1, 2000, Pages 18-29

  Metkar, Sunil S ^a   Anand, Mohanish ^b   Manna, Partha P ^a   Naresh, K N ^b   Nadkarni, J J ^a,b  

^a CANCER RESEARCH INSTITUTE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

Apoptosis; Caspases; Ceramide; Fas; Hodgkin's disease

Indexed keywords

CASPASE; CASPASE INHIBITOR; CERAMIDE; FAS ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; ENZYME INHIBITION; HODGKIN DISEASE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034712251     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4773     Document Type: Article

References (49)

1. Alnemri, E. S., Livingston, D. J., Nicholson, D. W., Salvesen, G., Thornberry, N. A., Wong, W. W., and Yuan, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171-175.
2. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y., and Seldin, M. F. (1995). Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447.
3. Cifone, G., Roncaioli, P., Maria, D., Camarda, G., Santoni, A., Ruberti, G., and Testi, R. (1995). Multiple pathways originate at the Fas/APO-1 (CD95) receptor: Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J. 14, 5859-5868.
4. Tepper, A. D., Jeanine, G. R., de Vries, E., Borst, J., and Blitterswijk, W. J. (1997). CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP-32 inhibition. J. Biol. Chem. 272, 24308-24312.
5. Testi, R. (1996). Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 21, 468-471.
6. Hannun, Y. A. (1996). Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859.
7. Kolesnick, R. N., and Kronke, M. (1998). Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 60, 643-665.
8. Mizushima, N., Koike, R., Kohsaka, H., Kushi, Y., Handa, S., Yagita, H., and Miyasaka, N. (1996). Ceramide induces apoptosis via CPP32 activation. FEBS Lett. 395, 267-271.
9. Steck, K. D., McDonell, T. J., and El-Naggar, A. K. (1995). Flow cytometric analysis of apoptosis and BCL2 in human solid neoplasms. Cytometry 20, 154-161.
10. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139, 271-279.
11. Vermes, I., Haanen, I., Steffens-Nakken, H., and Reutlin-sperger, C. (1995). A novel assay for apoptosis: Flow cytometric detection of phosphotidylserine expression on early apoptotic cells using fluorescein-labelled annexin V. J. Immunol. Methods 184, 39-51.
12. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J. L., Petit, P. X., and Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661-1672.
13. Splawski, J. B., Nishioka, J., Nishioka, Y., and Lipsky, P. E. (1996). CD40 Ligand is expressed and functional on activated neonatal T cells. J. Immunol. 156, 119-127.
14. Lens, S. M. A., Tesselar, K., den Drijver, B. F. A., van Oers, M. H. J., and van Lier, R. A. W. (1996). A dual role for both CD40 Ligand and TNFα in controlling human B cell death. J. Immunol. 156, 507-514.
15. Cascino, I., Papoff, G., De Maria, R., Testi, R., and Ruberti, G. (1996). Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. J. Immunol. 156, 7-13.
16. Boise, L. H., Garcia, M. G., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. (1993). bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
17. Papoff, G., Cascino, I., Eramo, A., Starace, G., Lynch, D. H., and Ruberti, G. (1996). An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol. 156, 4622-4630.
18. Herr, I., Wilhelm, D., Bohler, T., Angel, P., and Debatin, K. M. (1997). Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, 6200-6208.
19. Metkar, S. S., Naresh, K. N., Redkar, A. A., and Nadkarni, J. J. (1998). CD40-ligation mediated protection of a Fas-sensitive Hodgkin's disease derived cell line from apoptosis. Can. Immunol. Immunother. 47, 104-112.
20. Schaadt, M., Diehl, V., Stein, H., Fonatsch, C., and Kirschner, H. H. (1980) Two neoplastic cell lines with unique features derived from Hodgkin's disease. Int. J. Can. 26, 723-731.
21. Kamesaki, O. H., Fukuhara, S., Tatsumi, E., Uchino, H., Yamabe, H., Miwa, H., Shirakawa, S., Hatanaka, M., and Honjo, T. (1986). Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68, 285-292.
22. Metkar, S. S., Naresh, K. N., Redkar, A. A., Advani, S. H., Soman, C. S., and Nadkarni, J. J. (1999). Expression of Fas and Fas Ligand in Hodgkin's disease. Leukemia Lymph. 33, 521-530.
23. Chinnaiyan, A. M., Tepper, C. J., Seldin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. (1996). FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271, 4961-4965.
24. Itoh, N., Tsujimoto, Y., and Nagata, S. (1993). Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621-627.
25. Mandal, M., Maggirwar, S. B., Sharma, N., Kaufmann, S. H., Sun, S., and Kumar, R. (1996). Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly(ADP-ribose) polymerase and restores the NF-kappaB signaling pathway. J. Biol. Chem. 271, 30354-30359.
26. Memon, S. A., Morens, M. B., Petra, K. D., and Zacharchuck, C. M. (1995). Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155, 4644-4652.
27. Choi, M. S. K., Boise, L. N., Gottschalk, A. R., Quintans, J., Thomson, C. B., and Klaus, G. G. B. (1995). The role of bclx(L) in CD40 mediated rescue from anti-mu induced apoptosis in Wehi-231 B lymphoma cells. Eur. J. Immunol. 25, 1352-1357.
28. Merino, R., Grillot, D. A., Simonian, P. L., Muthukumar, S., Fanslow, W. C., Bondada, S., and Nunez, G. (1995). Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 155, 3830-3838.
29. Schneider, P., Bodmer, J. L., Thome, M., Hofmann, K., Holler, N., and Tschopp, J. (1997). Characterization of two receptors for TRAIL. FEBS Lett. 416, 329-334.
30. Wang, Z., Karras, J. G., Howard, R. G., and Rothstein, T. L. (1995). Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells. J. Immunol. 155, 3722-3725.
31. Cock, J. G. R., Tepper, A. D., de Vries, E., Blitterswijk, W. J., and Borst, J. (1998). CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J. Biol. Chem. 273, 7560-7565.
32. Genestier, L., Prigent, A. F., Paillot, R., Quemenuer, L., Durand, I., Banchereau, J., Revillard, J. P., and Berard, N. P. (1998). Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis. J. Biol. Chem. 273, 5060-5066.
33. Sawai, H., Okazaki, T., Takeda, M., Tashima, M., Sawada, H., Okuma, M., Kishi, S., Umehara, H., and Domae, N. (1997). Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. J. Biol. Chem. 272, 2452-2458.
34. Wright, S. C., Zheng, H., and Zhong, J. (1996). Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10, 325-332.
35. Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. A. (1990). Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265, 15823-15831.
36. Weisner, D. A., Kilkus, J. P., Gottschalk, J. R., Quintans, J., and Dawson, G. (1997). Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-xL. J. Biol. Chem. 272, 9868-9876.
37. Chmura, S. J., Nodzenski, E., Crane, M. A., Virudachalam, S., Hallahan, D. E., Weischselbaum, R. R., and Quintans, J. (1996). Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. Adv. Exp. Med. Biol. 406, 39-55.
38. Lee, S. Y., Reichlin, A., Santana, A., Sokol, K. A., Nussenweig, M. C., and Choi, Y. (1997). TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 7, 703-713.
39. Smyth, M. J., Perry, D. K., Zhang, J., Poirier, G. G., Hannun, Y. A., and Obeid, L. M. (1996). prICE: A downstream target for ceramide-induced apoptosis and for the inhibitory action of Bcl-2. Biochem. J. 316, 25-28.
40. Hartfield, P. J., Bilney, A. J., and Murray, A. W. (1997). Neurotrophic factors prevent ceramide-induced apoptosis down-stream of c-Jun N-terminal kinase activation in PC12 cells. J. Neurochem. 71, 161-169.
41. Spinedi, A., Amendola, A., Di Bartolomeo, S., and Piacentini, M. (1998). Ceramide-induced apoptosis is mediated by caspase activation independently from retinoblastoma protein post-translational modification. Biochem. Biophy. Res. Commun. 243, 852-857.
42. Hsu, S. C., Wu, C. C., Luh, T. Y., Chou, C. K., Han, S. H., and Lai, M. Z. (1998). Apoptotic signal of Fas is not mediated by ceramide. Blood 91, 2658-2663.
43. Watts, J. D., Gu, M., Polverino, A. J., Patterson, A. D., and Aebersold, R. (1997). Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc. Natl. Acad. Sci. USA 94, 7292-7296.
44. Lazebnik, Y. A., Kauffmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. (1994). Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
45. Nicholson, D. W., Ambereen, A., Thornberry, N. A., Vaillancourt, J. K., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 367, 37-43.
46. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyer, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvessen, G. S., and Dixit, V. M. (1995). Yama/CPP32 beta, mammalian homolog of CED-3, is a crmA inhibitable protease that cleaves the substrate poly (ADP-ribose) polymerase. Cell 81, 801-809.
47. Fernandes-Alnemri, T., Takahashi, A., Armstrong, R. C., Krebs, J., Fritz, L. C., Tommaselli, K. J., Wang, L., Lu, Z., Croce, M., Salvessen, G., et al. (1995). Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res. 55, 6045-6052.
48. Deas, O., Dumont, C., MacFarlane, M., Rouleau, M., Hebib, C., Harper, F., Hirsch, F., Charpentier, B., Cohen, G. C., and Senik, A. (1998). A caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J. Immunol. 161, 3375-3383.
49. Okuno, S., Shimizu, S., Ito, T., Nomura, M., Hamada, E., Tsujimoto, Y., and Matsuda, H. (1998). Bc1-2 prevents caspase-independent cell death. J. Biol. Chem. 273, 34272-34277.